194 related articles for article (PubMed ID: 11426446)
1. Exclusion of growth factor gene mutations as a common cause of Sotos syndrome.
Lin AE; Liu Q; Mannheim GB; Darras BT
Am J Med Genet; 2001 Jan; 98(1):101-2. PubMed ID: 11426446
[TBL] [Abstract][Full Text] [Related]
2. Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes.
Türkmen S; Gillessen-Kaesbach G; Meinecke P; Albrecht B; Neumann LM; Hesse V; Palanduz S; Balg S; Majewski F; Fuchs S; Zschieschang P; Greiwe M; Mennicke K; Kreuz FR; Dehmel HJ; Rodeck B; Kunze J; Tinschert S; Mundlos S; Horn D
Eur J Hum Genet; 2003 Nov; 11(11):858-65. PubMed ID: 14571271
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of NSD1 gene mutations in southern Chinese patients with Sotos syndrome.
Tong TM; Hau EW; Lo IF; Chan DH; Lam ST
Chin Med J (Engl); 2005 Sep; 118(18):1499-506. PubMed ID: 16232326
[TBL] [Abstract][Full Text] [Related]
4. NSD1 mutations in Sotos syndrome.
Faravelli F
Am J Med Genet C Semin Med Genet; 2005 Aug; 137C(1):24-31. PubMed ID: 16010675
[TBL] [Abstract][Full Text] [Related]
5. Two cases of Sotos syndrome with novel mutations of the NSD1 gene.
Fryssira H; Drossatou P; Sklavou R; Barambouti F; Manolaki N
Genet Couns; 2010; 21(1):53-9. PubMed ID: 20420030
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent time course of cerebral brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 in APP23 transgenic mice.
Schulte-Herbrüggen O; Eckart S; Deicke U; Kühl A; Otten U; Danker-Hopfe H; Abramowski D; Staufenbiel M; Hellweg R
J Neurosci Res; 2008 Sep; 86(12):2774-83. PubMed ID: 18438945
[TBL] [Abstract][Full Text] [Related]
7. Lymphoproliferative disorders in Sotos syndrome: observation of two cases.
Corsello G; Giuffrè M; Carcione A; Cuzto ML; Piccione M; Ziino O
Am J Med Genet; 1996 Sep; 64(4):588-93. PubMed ID: 8870927
[TBL] [Abstract][Full Text] [Related]
8. MLPA analysis in 30 Sotos syndrome patients revealed one total NSD1 deletion and two partial deletions not previously reported.
Fagali C; Kok F; Nicola P; Kim C; Bertola D; Albano L; Koiffmann CP
Eur J Med Genet; 2009; 52(5):333-6. PubMed ID: 19596467
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of NSD1 alterations in 116 patients with Sotos syndrome.
Saugier-Veber P; Bonnet C; Afenjar A; Drouin-Garraud V; Coubes C; Fehrenbach S; Holder-Espinasse M; Roume J; Malan V; Portnoi MF; Jeanne N; Baumann C; Héron D; David A; Gérard M; Bonneau D; Lacombe D; Cormier-Daire V; Billette de Villemeur T; Frébourg T; Bürglen L
Hum Mutat; 2007 Nov; 28(11):1098-107. PubMed ID: 17565729
[TBL] [Abstract][Full Text] [Related]
10. Three novel mutations in greek sotos patients with rare clinical manifestations.
Leventopoulos G; Kitsiou-Tzeli S; Psoni S; Mavrou A; Kanavakis E; Willems P; Fryssira H
Horm Res; 2009 Jan; 71(1):45-51. PubMed ID: 19039236
[TBL] [Abstract][Full Text] [Related]
11. Sotos syndrome and cutis laxa.
Robertson SP; Bankier A
J Med Genet; 1999 Jan; 36(1):51-6. PubMed ID: 9950366
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of tall stature.
Kant SG; Wit JM; Breuning MH
Horm Res; 2005; 64(3):149-56. PubMed ID: 16192740
[TBL] [Abstract][Full Text] [Related]
13. Psychosocial, cognitive, and motor functioning in patients with suspected Sotos syndrome: a comparison between patients with and without NSD1 gene alterations.
de Boer L; Röder I; Wit JM
Dev Med Child Neurol; 2006 Jul; 48(7):582-8. PubMed ID: 16780628
[TBL] [Abstract][Full Text] [Related]
14. Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition.
DeBaun MR; Ess J; Saunders S
Mol Genet Metab; 2001 Apr; 72(4):279-86. PubMed ID: 11286501
[TBL] [Abstract][Full Text] [Related]
15. Differential mRNA expression of neurotrophic factors GDNF, BDNF, and NT-3 in experimental herpes simplex virus encephalitis.
Sellner J; Lenhard T; Haas J; Einsiedel Rv; Meyding-Lamadé U
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):267-71. PubMed ID: 15950786
[TBL] [Abstract][Full Text] [Related]
16. BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures.
Kamei N; Tanaka N; Oishi Y; Hamasaki T; Nakanishi K; Sakai N; Ochi M
Spine (Phila Pa 1976); 2007 May; 32(12):1272-8. PubMed ID: 17515814
[TBL] [Abstract][Full Text] [Related]
17. Lingual deficits in neurotrophin double knockout mice.
Nosrat IV; Agerman K; Marinescu A; Ernfors P; Nosrat CA
J Neurocytol; 2004 Dec; 33(6):607-15. PubMed ID: 16217617
[TBL] [Abstract][Full Text] [Related]
18. Child with Sotos phenotype and a 5:15 translocation.
Maroun C; Schmerler S; Hutcheon RG
Am J Med Genet; 1994 Apr; 50(3):291-3. PubMed ID: 8042674
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophic factors expressed in both cortex and spinal cord induce axonal plasticity after spinal cord injury.
Zhou L; Shine HD
J Neurosci Res; 2003 Oct; 74(2):221-6. PubMed ID: 14515351
[TBL] [Abstract][Full Text] [Related]
20. Low factor XII level in an individual with Sotos syndrome.
Shen JJ; Kurotaki N; Patel A; Lupski JR; Brown CW
Pediatr Blood Cancer; 2005 Feb; 44(2):187-9. PubMed ID: 15390361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
